D

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Medical Director - Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA$270k - $310kIn-person

About the Job

Requirements

  • A Doctor of Medicine degree is required; board certification or advanced training in neurology, neuroscience, neuromuscular disease, pediatrics, internal medicine, or a related specialty is preferred, or another relevant degree.
  • At least 5 years of relevant experience, including at least 3 years in clinical development, medical monitoring, pharmacovigilance, clinical research, or related roles within the pharmaceutical or biotechnology industry.
  • Experience serving as a medical monitor or providing medical oversight for interventional clinical trials.
  • A strong understanding of clinical trial design, protocol execution, medical data review, safety monitoring, and clinical development processes.
  • Working knowledge of FDA, EMA, ICH, GCP, and other applicable regulatory requirements for clinical trials.
  • Regulatory experience with Pre-INDs, INDs, CTAs, EOP 2 meetings, and NDA/BLA/MAA submissions in the United States and ex-US.
  • Experience reviewing and contributing to clinical and regulatory documents, including protocols, informed consent forms, investigator brochures, clinical study reports, safety narratives, briefing materials, and regulatory responses.
  • Ability to interpret clinical, safety, biomarker, pharmacodynamic, and efficacy data and translate findings into clear medical recommendations.
  • Strong clinical judgment and ability to assess participant safety, protocol eligibility, adverse events, and medically complex study questions.
  • Ability to work effectively in a fast-paced, matrixed biotechnology environment with cross-functional partners and external vendors.
  • Ability to collaborate, influence without authority, build alignment, and drive practical solutions across teams.
  • Written, verbal, and presentation skills to communicate complex medical and scientific information clearly to internal and external audiences.
  • Strong attention to detail and organizational skills, with the ability to manage multiple priorities while maintaining high-quality execution.
  • Ability to operate with appropriate independence, sound judgment, urgency, and accountability.
  • Ability and willingness to contribute hands-on across strategic and executional activities in a growing clinical-stage biotechnology company.
  • Ability to travel as needed for investigator meetings, site engagement, advisory boards, congresses, and internal meetings.

Responsibilities

  • Contribute to planning, design, development, and implementation of clinical trials for assigned drug candidates.
  • Apply knowledge of disease mechanisms to support selection and interpretation of biomarkers, pharmacodynamic and clinical endpoints, and patient stratification considerations.
  • Contribute to developing and implementing studies to establish the safety, tolerability, pharmacodynamic activity, and efficacy of assigned drug candidates.
  • Contribute to integrated product and clinical development plans and align medical monitoring activities with broader program objectives.
  • Provide medical input to Research, Translational Medicine, Biomarkers, and other cross-functional partners on decisions with clinical components and implications.
  • Serve as medical monitor for assigned studies and provide timely medical guidance to study teams, investigators, CROs, vendors, and advisors.
  • Review clinical and safety data, eligibility questions, protocol deviations, adverse events, serious adverse events, and other medically relevant information to support participant safety and study integrity.
  • Partner with Pharmacovigilance and Clinical Development leadership on safety surveillance, signal detection, benefit-risk assessment, and timely escalation of emerging safety concerns.
  • Support study-level risk assessments, medical monitoring plans, data review plans, dose review discussions, and safety review meetings.
  • Collaborate with Clinical Operations to ensure assigned study activities comply with applicable regulations, GCP, ICH guidelines, Dyne SOPs, and study timelines.
  • Ensure compliance with applicable regulatory standards for global clinical trials and interactions with physicians.
  • Support development, implementation, and maintenance of SOPs for clinical trials and related activities.
  • Support site engagement, investigator training, enrollment strategy, medical issue resolution, and inspection readiness for assigned studies.
  • Partner with Clinical Operations on outsourcing and in-house approaches for clinical development capabilities and implementation plans.
  • Manage relationships with CROs, vendors, and external collaborative partners supporting clinical development efforts.
  • Review and interpret emerging clinical, safety, biomarker, pharmacodynamic, and endpoint data to inform study conduct, program strategy, and regulatory interactions.
  • Contribute medical review and interpretation to protocols, investigator brochures, informed consent forms, clinical study reports, briefing materials, safety narratives, and regulatory responses.
  • Support regulatory submissions and interactions with health authorities by providing study-specific medical input and data interpretation.
  • Represent the company in interactions with regulatory agencies, as required.
  • Manage the writing, review, and accountability for key clinical and regulatory documents, including protocols, investigator brochures, informed consent forms, regulatory submissions, abstracts, peer-reviewed articles, presentations, and publications.
  • Support abstracts, presentations, publications, and other scientific communications, as appropriate.
  • Identify, manage, and interface with external collaborators, investigators, advisors, and key opinion leaders to support clinical development strategies for a novel class of therapeutics.
  • Develop and maintain professional relationships with academic and community-based study sites.
  • Participate, as requested, in Business Development due diligence, advisory boards, investigator meetings, and presentations to external constituencies.
  • Maintain accountability for relevant timelines and deliverables in partnership with functional counterparts and clinical development colleagues.
  • Coordinate and communicate with internal departments and external vendors to ensure study objectives, timelines, and deliverables are accomplished.
  • Manage, coordinate, and provide ongoing assessment, evaluation, and communication with internal departments and external vendors to support successful study execution.
  • Provide timely updates to Clinical Development leadership and cross-functional partners on study progress, medical issues, emerging risks, changes in scope, schedule, and resources.
  • Interface with functions within and outside of R&D, including Finance, Regulatory Affairs, Legal, Commercial, and Medical Affairs.
  • Provide leadership and mentorship to clinical development team members, including matrixed team members and potential direct reports.

Desired Qualifications

  • Board certification or advanced training in neurology, neuroscience, neuromuscular disease, pediatrics, internal medicine, or a related specialty.
  • Experience in rare disease, neuromuscular disease, genetic medicines, oligonucleotide therapeutics, or other complex therapeutic areas.
  • Experience working with CROs, investigators, study sites, and external experts.

About the Company

Dyne Therapeutics

Develops muscle-disease therapies using FORCE platform

Dyne Therapeutics develops therapies for serious muscle diseases using its FORCE™ platform, which helps deliver oligonucleotide medicines to muscle tissue. Through a portfolio of experimental therapies, the company advances them in clinical trials (ACHIEVE and DELIVER) with the aim of treating rare muscle diseases. The product works by enhancing targeted delivery of oligonucleotides to muscle, enabling existing genetic medicines to reach affected tissues more effectively. Dyne differentiates itself by its proprietary FORCE™ technology and its focus on rare muscle diseases, positioning itself for growth as trials progress toward potential commercialization. The company’s goal is to bring effective treatments to patients and families affected by serious muscle diseases, expanding options as its therapies advance through development and, potentially, regulatory approval.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Dyne Therapeutics

See more jobs